Aptevo Therapeutics Inc.
APVO
$4.83
-$0.02-0.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 148.10% | 171.65% | 16.66% | -79.13% | -48.45% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 123.89% | -7.58% | 99.12% | 18.98% | -37.20% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -16.37% | -87.66% | -88.53% | -82.63% | 48.04% |
| Total Current Assets | 116.54% | 126.22% | 15.68% | -70.13% | -44.09% |
|
|
|||||
| Total Current Assets | 116.54% | 126.22% | 15.68% | -70.13% | -44.09% |
| Net Property, Plant & Equipment | -16.61% | -15.33% | -14.96% | -14.76% | -14.61% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 74.42% | 78.24% | 4.71% | -52.68% | -37.24% |
|
|
|||||
| Total Accounts Payable | -29.39% | -37.17% | -22.30% | 1.85% | -68.83% |
| Total Accrued Expenses | 2.62% | 106.18% | 16.59% | -70.68% | 100.05% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.76% | 14.29% | 14.29% | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -4.67% | 62.64% | 322.39% | -- |
| Total Other Current Liabilities | -- | -4.67% | 62.64% | 322.39% | -- |
| Total Current Liabilities | -2.53% | -4.56% | -9.74% | -14.37% | -14.08% |
|
|
|||||
| Total Current Liabilities | -2.53% | -4.56% | -9.74% | -14.37% | -14.08% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -18.71% | -17.39% | -16.24% | -15.19% | -14.23% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -9.44% | -10.46% | -12.99% | -14.84% | -14.14% |
|
|
|||||
| Common Stock & APIC | 15.92% | 16.66% | 10.84% | 6.82% | 7.07% |
| Retained Earnings | -11.12% | -11.59% | -10.17% | -10.29% | -10.80% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 265.53% | 293.48% | 46.18% | -124.14% | -61.09% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 265.53% | 293.48% | 46.18% | -124.14% | -61.09% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 265.53% | 293.48% | 46.18% | -124.14% | -61.09% |
|
|
|||||